Reckitt's Q1 VMS Results Exceed Expectations Driven By Sales In China

Reckitt’s VMS product sales exceeded expected 4% to 5% Q1 growth due to strong sales in China. Company also increased 2022 guidance due to a strong start. 

• Source: Alamy

Reckitt Benckiser Group PLC reported sales of its vitamin, mineral and supplement products grew in the mid-teens on its Move Free and our Neuriva health brands in China, driving overall health category sales up 20.6%.

“Our brands are doing extremely well digitally, as we see strong sell-out through e-commerce,” said CEO Laxman Narasimhan during the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Earnings

More from Business